Moolec Science (MLEC) Interest Expenses (2023 - 2025)
Moolec Science (MLEC) reported Interest Expenses of $38.1 million for Q2 2025, up 202.1% on a YoY basis from $12.6 million in Q2 2024, and up 345.76% sequentially from -$15.5 million in Q4 2024.
Moolec Science (MLEC) Interest Expenses (2023 - 2025) Analysis & Trends
Moolec Science (MLEC) has 3 years of Interest Expenses data on file, last reported at $38.1 million in Q2 2025.
- For the quarter ending Q2 2025, Interest Expenses rose 202.1% year-over-year to $38.1 million; the trailing twelve-month figure through Mar 2026 stood at -$16.0 million (changed N/A YoY), and the FY2025 full-year result was -$41.8 million, down 11.09% from the prior year.
- Interest Expenses improved to $38.1 million in Q2 2025, from -$15.5 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $38.1 million in Q2 2025 to a low of -$37.3 million in Q2 2024.
- A 3-year average of $69140.9 and a median of -$454499.0 in 2024 frame the typical range for Interest Expenses.
- Across the five-year window, Interest Expenses tumbled 453.39% in 2024 and jumped 202.1% in 2025, its largest moves.
- Tracing MLEC's Interest Expenses over 3 years: stood at -$14.3 million in 2023, then declined by 8.37% to -$15.5 million in 2024, then jumped by 345.76% to $38.1 million in 2025.
- Business Quant data shows MLEC's Interest Expenses at $38.1 million in Q2 2025, -$15.5 million in Q4 2024, and -$550170.0 in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | Moolec Science | 5.21 Bn | 5.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 38.08 Mn |
| Jun 30, 2025 | 38.08 Mn |
| Dec 31, 2024 | -15.49 Mn |
| Dec 31, 2024 | -15.49 Mn |
| Sep 30, 2024 | -550,170.00 |
| Sep 30, 2024 | -550,170.00 |
| Jun 30, 2024 | -37.29 Mn |
| Jun 30, 2024 | -37.29 Mn |
| Mar 31, 2024 | -358,828.00 |
| Mar 31, 2024 | -358,828.00 |
| Dec 31, 2023 | -14.30 Mn |
| Dec 31, 2023 | -14.30 Mn |
| Sep 30, 2023 | -99,419.00 |
| Sep 30, 2023 | -99,419.00 |
| Jun 30, 2023 | 30.57 Mn |
| Jun 30, 2023 | 30.57 Mn |